Ads
related to: merck
Search results
Analyst Report: Merck & Co., Inc.
Morningstar Research via Yahoo Finance· 3 hours agoMerck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, ...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 12 hours agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via AOL· 13 hours ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecast on the back of...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 13 hours agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents this decade
Quartz· 4 hours agoPharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 5 hours agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
Dow Jones Darling Merck Pops As Cancer 'Star' Drives Quarterly Beat
Investor's Business Daily· 10 hours agoMerck's bread-and-butter cancer drug grew by double digits again in the first quarter.
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 hours agoImage source: The Motley Fool. Merck (NYSE: MRK) Q1 2024 Earnings Call Apr 25, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 13 hours agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
Bloomberg· 13 hours agoMerck & Co. raised its annual profit and revenue forecast as the blockbuster cancer drug Keytruda...
